Other News To Note
Tuesday, May 17, 2011
NeuroHealing Pharmaceuticals Inc., of Newton, Mass., entered a strategic master services and investment deal with Cato BioVentures, which includes a collaboration with Cato Research Ltd., its contract research organization, to assist in the clinical development of NeuroHealing's lead drug NH001.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.